← SynDRA
TACALCITOL
SynDRA canonical compound SYN0031501 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | VDR |
| Mechanism of action | vitamin D receptor agonist |
| Indication | chapped lips | psoriasis |
| Disease area | dermatology |
All known targets
Mechanisms of action (all sources)
- vitamin D receptor agonist
Drug classes
- Anti-Inflammatory Agents
- Dermatologic Agents
ATC classes
- D05A · ANTIPSORIATICS FOR TOPICAL USE
Cross-references
Synonyms
- 1.alpha.,24-dihydroxyvitamin d3
- Bonalfa
- Curatoderm
- Bonalfa (TN)
- Tacalcitolum
- TV-02H
- TV 02
- UNII-C2W72OJ5ZU
- PRI-2191
- 1-alpha,24(R)-Dihydroxyvitamin D3
- (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- C2W72OJ5ZU
- 1alpha,24(R)-Dihydroxyvitamin D3
- Tacalcitol (INN)
- TACALCITOL [INN]
- 1,24-Dihydroxyvitamin D3
- (24R)-1alpha,24-dihydroxyvitamin D3 / (24R)-1alpha,24-dihydroxycholecalciferol
- (5Z,7E)-(1S,3R,24R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
- (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R)-5-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
- Tacalcitolum [INN-Latin]
- 1,24(R)-Dihydroxyvitamin D3
- CHEBI:32176
- Tacalcitol [INN:BAN:JAN]
- Vellutan
- Apsor
- CCRIS 4211
- tv02
- TACALCITOL [MI]
- 1alpha,24(OH)2D3
- SCHEMBL3945
- TACALCITOL [MART.]
- TACALCITOL [WHO-DD]
- TV-02HS
- 1a,24-Dihydroxycholecalciferol
- GTPL2780
- CHEMBL2105611
- Tacalcitol, >=99% (HPLC)
- DTXSID90905111
Look up TACALCITOL in the interactive SynDRA portal →